πŸ‡ΊπŸ‡Έ FDA
Patent

US 9597353

Redox signaling gel formulation

granted A61KA61K31/78A61K33/00

Quick answer

US patent 9597353 (Redox signaling gel formulation) held by Reoxcyn Discoveries Group, Inc. expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Reoxcyn Discoveries Group, Inc.
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/78, A61K33/00, A61K33/06, A61K33/14